---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292217203.md"
description: "Connect Biopharma shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $8."
datetime: "2026-07-09T14:57:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292217203.md)
  - [en](https://longbridge.com/en/news/292217203.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292217203.md)
generator: "portal-rs"
---

# 

Connect Biopharma shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $8.

### Related Stocks

- [CNTB.US](https://longbridge.com/en/quote/CNTB.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)

## Related News & Research

- [Top 3 Health Care Stocks That May Keep You Up At Night In Q3](https://longbridge.com/en/news/297190336.md)
- [Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't?](https://longbridge.com/en/news/296885075.md)
- [Rhythm Pharmaceuticals (RYTM) Could Be 15% Undervalued As Japan Approval Lifts Its Story](https://longbridge.com/en/news/297007083.md)
- [Why Arcus Biosciences (RCUS) Is Getting Attention Today](https://longbridge.com/en/news/296943867.md)
- [How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval](https://longbridge.com/en/news/297146976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**